Abstract
Introduction
NUT midline carcinoma is a rare tumour occurring in young adults which is frequently misdiagnosed as poorly differentiated squamous cell carcinoma or germ cell tumour. Though considered highly aggressive, there is limited information about the clinical behaviour of such patients. We intended to perform this review of published literature to assess the demographic profile, pattern of care and assess survival outcomes.
Methods
Two authors independently searched PubMed and Google search for eligible studies from 1950 till July 1 2017 published in English language using MESH terms NUT midline carcinoma; NUT midline carcinoma and radiotherapy and translocation 15:19 tumour.
Results
Data of 119 patients were retrieved from 64 publications for statistical analysis. Median age of the entire cohort was 23 years (range 0–68 years). The analysis revealed equal incidence in males and females (60:58). The present analysis revealed that the most common location is the lung (n = 42) followed by head and neck (n = 40). Median OS for the entire cohort was only 5 months with 1 and 5 year OS for the entire cohort was 24.99 and 7.09% respectively. Radiotherapy and chemotherapy inclusion in primary treatment had a significant impact on overall survival on univariate analysis while surgery did not affect survival significantly. No impact on overall survival was found based on type of molecular translocation, i.e., NUT–BRD4, NUT–BRD3 or other variants. Inadequate data were available for identify impact of BET inhibitors and HiDAc on PFS and OS.
Conclusion
NUT midline carcinoma has dismal prognosis. Radiotherapy and chemotherapy improves survival, but do not provide long term control except in anecdotal cases. Further research is needed to improve outcomes in future.
Similar content being viewed by others
References
Ciftci E, Demirsoy U, Anik Y, Gorur G, Corapcioglu F, Demir H (2015) Staging and evaluation of neoadjuvant chemotherapy response with 18F-FDG PET/CT in NUT-midline carcinoma in a child: a case report and review of the literature. Rev Esp Med Nucl Imagen Mol. 34(1):53–55
Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Luer SC et al (2012) Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res 18(20):5773–5779
Chau NG, Hurwitz S, Mitchell CM, Aserlind A, Grunfeld N, Kaplan L et al (2016) Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck. Cancer 122(23):3632–3640
French CA (2010) Demystified molecular pathology of NUT midline carcinomas. J Clin Pathol 63(6):492–496
Stelow EB (2011) A review of NUT midline carcinoma. Head Neck Pathol 5(1):31–35
Stathis A, Zucca E, Bekradda M, Gomez-Roca C, Delord JP, de La Motte Rouge T et al (2016) Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628. Cancer Discov 6(5):492–500
Benito Bernáldez C, Romero Muñoz C, Almadana Pacheco V (2016) NUT midline carcinoma of the lung, a rare form of lung cancer. Arch Bronconeumol 52(12):619–621
Mertens F, Wiebe T, Adlercreutz C, Mandahl N, French CA (2007) Successful treatment of a child with t(15;19)-positive tumor. Pediatr Blood Cancer 49(7):1015–1017
Lemelle L, Pierron G, Fréneaux P, Huybrechts S, Spiegel A, Plantaz D et al (2017) NUT carcinoma in children and adults: a multicenter retrospective study. Pediatr Blood Cancer 64(12). https://doi.org/10.1002/pbc.26693
Dang TP, Gazdar AF, Virmani AK (2000) Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. J Natl Cancer Inst 92:1355–1357
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial support
No financial support received.
Conflict of interest
The authors have no conflict of interest.
Human participants and animals statement
Not applicable.
Rights and permissions
About this article
Cite this article
Giridhar, P., Mallick, S., Kashyap, L. et al. Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases. Eur Arch Otorhinolaryngol 275, 815–821 (2018). https://doi.org/10.1007/s00405-018-4882-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-018-4882-y